Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
[primary hyperoxaluria type 1]
Human
liver
peroxisomal
alanine
:
glyoxylate
aminotransferase
(
AGT
)
is
a
pyridoxal
5
'
-
phosphate
(
PLP
)
-
dependent
enzyme
that
converts
glyoxylate
into
glycine
.
AGT
deficiency
causes
primary
hyperoxaluria
type
1
(
PH
1
)
,
a
rare
autosomal
recessive
disorder
,
due
to
a
marked
increase
in
hepatic
oxalate
production
.
Normal
human
AGT
exists
as
two
polymorphic
variants
:
the
major
(
AGT
-Ma
)
and
the
minor
(
AGT
-Mi
)
allele
.
AGT
-Mi
causes
the
PH
1
disease
only
when
combined
with
some
mutations
.
In
this
study
,
the
molecular
basis
of
the
synergism
between
AGT
-Mi
and
F
152
I
mutation
has
been
investigated
through
a
detailed
biochemical
characterization
of
AGT
-Mi
and
the
Phe
(
152
)
variants
combined
either
with
the
major
(
F
152
I
-Ma
,
F
152
A
-Ma
)
or
the
minor
allele
(
F
152
I
-Mi
)
.
Although
these
species
show
spectral
features
,
kinetic
parameters
,
and
PLP
binding
affinity
similar
to
those
of
AGT
-Ma
,
the
Phe
(
152
)
variants
exhibit
the
following
differences
with
respect
to
AGT
-Ma
and
AGT
-Mi
:
(
i
)
pyridoxamine
5
'
-
phosphate
(
PMP
)
is
released
during
the
overall
transamination
leading
to
the
conversion
into
apoenzymes
,
and
(
ii
)
the
PMP
binding
affinity
is
at
least
200
-
1400
-
fold
lower
.
Thus
,
Phe
(
152
)
is
not
an
essential
residue
for
transaminase
activity
,
but
plays
a
role
in
selectively
stabilizing
the
AGT
-
PMP
complex
,
by
a
proper
orientation
of
Trp
(
108
)
,
as
suggested
by
bioinformatic
analysis
.
These
data
,
together
with
the
finding
that
apoF
152
I
-Mi
is
the
only
species
that
at
physiological
temperature
undergoes
a
time-dependent
inactivation
and
concomitant
aggregation
,
shed
light
on
the
molecular
defects
resulting
from
the
association
of
the
F
152
I
mutation
with
AGT
-Mi
,
and
allow
to
speculate
on
the
responsiveness
to
pyridoxine
therapy
of
PH
1
patients
carrying
this
mutation
.
Diseases
Validation
Diseases presenting
"hyperoxaluria"
symptom
cystinuria
neonatal adrenoleukodystrophy
primary hyperoxaluria type 1
This symptom has already been validated